Market Overview:
The global heparin calcium market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for heparin calcium injection and powder due to its various therapeutic benefits. Additionally, the growing prevalence of cardiovascular diseases and rising geriatric population are also contributing factors for the growth of this market. However, stringent regulatory norms and high cost associated with R&D are some of the major factors restraining the growth of this market. On basis on type, heparin calcium injection is expected to account for a larger share in terms revenue as compared to heparin calcium powder during forecast period from 2018-2030 owing its higher usage rates across various applications such as unfractionated heparin (UFH) and low molecular weight heparins (LMWHs). Heparin Calcium Injection segment is further sub-segmented into preservative free & non-preservative free segments while Powder segment is further sub-segmented into lyophilized & non-lyophilized segments On basis on application, UFH accounted for majority share in terms revenue followed by LMWHs during 2017 owing its widespread use across medical treatments such as deep vein thrombosis prophylaxis (DVT), pulmonary embolism prophylaxis (PEP), myocardial infarction treatment etc.
Product Definition:
Heparin calcium is a heparinoid used as an anticoagulant. It is a mixture of sulfated polysaccharides derived from either natural or synthetic sources. Heparin calcium inhibits the activation of factor X by thrombin, and also blocks the interaction of factors XIa and XIIa with fibrinogen.
Heparin Calcium Injection:
Heparin calcium is a form of anticoagulant drug which works by preventing the blood from clotting. Heparin calcium injection is used in the treatment of coronary artery disease, deep vein thrombosis, pulmonary embolism and to prevent bleeding after surgery. The major factor that propels growth in this market includes rising geriatric population base coupled with growing incidences of cardiovascular diseases across the globe.
Heparin Calcium Powder:
Heparin calcium is a form of anticoagulant drug used to prevent blood clotting. It works by interfering with the normal function of proteins that help blood to clot. Heparin calcium powder is used in the treatment of deep vein thrombosis, pulmonary embolism, and heart attack among others. The rising prevalence rate of cardiovascular diseases across the globe coupled with increasing demand for anticoagulants are some major factors driving heparin calcium market growth globally.
Application Insights:
Based on the application, the global market is segmented into unfractionated heparin, low molecular weight heparin API and others. The low molecular weight heparin API segment dominated the overall market in terms of revenue share in 2017. Factors such as increasing usage of low-molecular-weight Heparin (LMWH) for various applications including anticoagulant therapy and coumarins are presumed to be responsible for this growth.
The other application segment includes surgical procedures involving blood vessels or veins such as venous thrombectomy, embolization etc. Venous thrombectomy is expected to be one of the fastest growing segments over the forecast period owing to its rising use during cancer treatment along with other applications such as pulmonary embolism (PE).
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The region is expected to maintain its dominance over the forecast period as well owing to factors such as favorable reimbursement policies, increasing geriatric population, rising awareness about new treatment options and presence of major manufacturers.
Asia Pacific is anticipated to be the fastest-growing regional market from 2018 to 2030 due to factors such as improving healthcare infrastructure and economic development. In addition, growing target population base with high unmet medical needs will drive growth further. Moreover, availability of low-cost raw materials for production will also help boost demand for heparin calcium products in this region over the forecast period.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs) is expected to drive the demand for heparin calcium over the forecast period.
- Growing geriatric population is also anticipated to boost the market growth as this population is more susceptible to CVDs.
- Rising awareness about the benefits of using heparin calcium in prevention and treatment of CVDs is projected to propel market growth during the forecast period.
- Technological advancements in heparin calcium products are likely to create new opportunities for market players over the next few years. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Heparin Calcium Market Research Report
By Type
Heparin Calcium Injection, Heparin Calcium Powder
By Application
Unfractionated Heparin, Low molecular Heparin API
By Companies
Changshan Biochemical, Opocrin, Tiandong Pharmaceutical, Yantai Dongcheng Biochemicals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Heparin Calcium Market Report Segments:
The global Heparin Calcium market is segmented on the basis of:
Types
Heparin Calcium Injection, Heparin Calcium Powder
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Unfractionated Heparin, Low molecular Heparin API
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Changshan Biochemical
- Opocrin
- Tiandong Pharmaceutical
- Yantai Dongcheng Biochemicals
Highlights of The Heparin Calcium Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Heparin Calcium Injection
- Heparin Calcium Powder
- By Application:
- Unfractionated Heparin
- Low molecular Heparin API
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Heparin Calcium Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Heparin calcium is a medication used to prevent blood clots. It works by stopping the formation of blood clots in the veins.
Some of the major players in the heparin calcium market are Changshan Biochemical, Opocrin, Tiandong Pharmaceutical, Yantai Dongcheng Biochemicals.
The heparin calcium market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Heparin Calcium Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Heparin Calcium Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Heparin Calcium Market - Supply Chain
4.5. Global Heparin Calcium Market Forecast
4.5.1. Heparin Calcium Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Heparin Calcium Market Size (000 Units) and Y-o-Y Growth
4.5.3. Heparin Calcium Market Absolute $ Opportunity
5. Global Heparin Calcium Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Heparin Calcium Market Size and Volume Forecast by Type
5.3.1. Heparin Calcium Injection
5.3.2. Heparin Calcium Powder
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Heparin Calcium Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Heparin Calcium Market Size and Volume Forecast by Application
6.3.1. Unfractionated Heparin
6.3.2. Low molecular Heparin API
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Heparin Calcium Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Heparin Calcium Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Heparin Calcium Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Heparin Calcium Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Heparin Calcium Demand Share Forecast, 2019-2026
9. North America Heparin Calcium Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Heparin Calcium Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Heparin Calcium Market Size and Volume Forecast by Application
9.4.1. Unfractionated Heparin
9.4.2. Low molecular Heparin API
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Heparin Calcium Market Size and Volume Forecast by Type
9.7.1. Heparin Calcium Injection
9.7.2. Heparin Calcium Powder
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Heparin Calcium Demand Share Forecast, 2019-2026
10. Latin America Heparin Calcium Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Heparin Calcium Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Heparin Calcium Market Size and Volume Forecast by Application
10.4.1. Unfractionated Heparin
10.4.2. Low molecular Heparin API
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Heparin Calcium Market Size and Volume Forecast by Type
10.7.1. Heparin Calcium Injection
10.7.2. Heparin Calcium Powder
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Heparin Calcium Demand Share Forecast, 2019-2026
11. Europe Heparin Calcium Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Heparin Calcium Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Heparin Calcium Market Size and Volume Forecast by Application
11.4.1. Unfractionated Heparin
11.4.2. Low molecular Heparin API
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Heparin Calcium Market Size and Volume Forecast by Type
11.7.1. Heparin Calcium Injection
11.7.2. Heparin Calcium Powder
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Heparin Calcium Demand Share, 2019-2026
12. Asia Pacific Heparin Calcium Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Heparin Calcium Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Heparin Calcium Market Size and Volume Forecast by Application
12.4.1. Unfractionated Heparin
12.4.2. Low molecular Heparin API
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Heparin Calcium Market Size and Volume Forecast by Type
12.7.1. Heparin Calcium Injection
12.7.2. Heparin Calcium Powder
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Heparin Calcium Demand Share, 2019-2026
13. Middle East & Africa Heparin Calcium Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Heparin Calcium Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Heparin Calcium Market Size and Volume Forecast by Application
13.4.1. Unfractionated Heparin
13.4.2. Low molecular Heparin API
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Heparin Calcium Market Size and Volume Forecast by Type
13.7.1. Heparin Calcium Injection
13.7.2. Heparin Calcium Powder
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Heparin Calcium Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Heparin Calcium Market: Market Share Analysis
14.2. Heparin Calcium Distributors and Customers
14.3. Heparin Calcium Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Changshan Biochemical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Opocrin
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Tiandong Pharmaceutical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Yantai Dongcheng Biochemicals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
